A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis
Brian S White,Xing Yi Woo,Soner Koc,Todd Sheridan,Steven B Neuhauser,Shidan Wang,Yvonne A Evrard,Li Chen,Ali Foroughi Pour,John D Landua,R Jay Mashl,Sherri R Davies,Bingliang Fang,Maria Gabriela Rosa,Kurt W Evans,Matthew H Bailey,Yeqing Chen,Min Xiao,Jill C Rubinstein,Brian J Sanderson,Michael W Lloyd,Sergii Domanskyi,Lacey E Dobrolecki,Maihi Fujita,Junya Fujimoto,Guanghua Xiao,Ryan C Fields,Jacqueline L Mudd,Xiaowei Xu,Melinda G Hollingshead,Shahanawaz Jiwani,Saul Acevedo,PDXNet Consortium,Brandi N Davis-Dusenbery,Peter N Robinson,Jeffrey A Moscow,James H Doroshow,Nicholas Mitsiades,Salma Kaochar,Chong-Xian Pan,Luis G Carvajal-Carmona,Alana L Welm,Bryan E Welm,Ramaswamy Govindan,Shunqiang Li,Michael A Davies,Jack A Roth,Funda Meric-Bernstam,Yang Xie,Meenhard Herlyn,Li Ding,Michael T Lewis,Carol J Bult,Dennis A Dean 2nd,Jeffrey H Chuang
DOI: https://doi.org/10.1158/0008-5472.CAN-23-1349
2024-07-02
Abstract:Patient-derived xenografts (PDX) model human intra- and intertumoral heterogeneity in the context of the intact tissue of immunocompromised mice. Histologic imaging via hematoxylin and eosin (H&E) staining is routinely performed on PDX samples, which could be harnessed for computational analysis. Prior studies of large clinical H&E image repositories have shown that deep learning analysis can identify intercellular and morphologic signals correlated with disease phenotype and therapeutic response. In this study, we developed an extensive, pan-cancer repository of >1,000 PDX and paired parental tumor H&E images. These images, curated from the PDX Development and Trial Centers Research Network Consortium, had a range of associated genomic and transcriptomic data, clinical metadata, pathologic assessments of cell composition, and, in several cases, detailed pathologic annotations of neoplastic, stromal, and necrotic regions. The amenability of these images to deep learning was highlighted through three applications: (i) development of a classifier for neoplastic, stromal, and necrotic regions; (ii) development of a predictor of xenograft-transplant lymphoproliferative disorder; and (iii) application of a published predictor of microsatellite instability. Together, this PDX Development and Trial Centers Research Network image repository provides a valuable resource for controlled digital pathology analysis, both for the evaluation of technical issues and for the development of computational image-based methods that make clinical predictions based on PDX treatment studies. Significance: A pan-cancer repository of >1,000 patient-derived xenograft hematoxylin and eosin-stained images will facilitate cancer biology investigations through histopathologic analysis and contributes important model system data that expand existing human histology repositories.